Alterations in the DNA binding protein methyl CpG-binding protein 2 (MeCP2) levels are known to affect neurodevelopmental disorders such as autism spectrum disorders, mental retardation, learning disabilities, Rett syndrome, repetitive behavior, hypotonia, and anxiety [73,74,75]. The gene discussed is MECP2; the disease is learning disability.